The potential of a newly developed transgenic mouse liver platform in the investigation of hepatocellular carcinoma and perspectives on PARP inhibitor-based therapy
Fields of Study & Subjects
PARP inhibition in cancer therapy
Hepatocellular Carcinoma Treatment and Prognosis
Cancer Research and Treatments
Publication details
- Journal / source
- SZTE Repository of Dissertations (University of Szeged)
- Publication date
- 31 March 2026
- Language
- EN
- Document type
- Thesis